Emerging role of long non-coding RNAs in cancer precision medicine

Aritro Nath, R. Stephanie Huang

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.

Original languageEnglish (US)
Article number1684130
JournalMolecular and Cellular Oncology
Issue number1
StatePublished - Jan 2 2020

Bibliographical note

Publisher Copyright:
© 2019, © 2019 Taylor & Francis Group, LLC.


  • Long non-coding RNA
  • drug response prediction
  • pharmacogenomics


Dive into the research topics of 'Emerging role of long non-coding RNAs in cancer precision medicine'. Together they form a unique fingerprint.

Cite this